The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 7,903 | 1,450,000 | SH | SOLE | 1,450,000 | 0 | 0 | ||
AERIE PHARMACEUTICALS INC | COM | 00771V108 | 4,325 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 5,698 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 3,987 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 14,448 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ATHENEX INC | COM | 04685N103 | 6,356 | 522,500 | SH | SOLE | 522,500 | 0 | 0 | ||
AVROBIO INC | COM | 05455M100 | 2,192 | 155,253 | SH | SOLE | 155,253 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 13,662 | 675,000 | SH | SOLE | 675,000 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS | COM | 09058V103 | 4,298 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 14,602 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 12,469 | 185,000 | SH | SOLE | 185,000 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 23,878 | 325,000 | SH | SOLE | 325,000 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 2,253 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
CHIASMA INC | COM | 16706W102 | 1,893 | 382,500 | SH | SOLE | 382,500 | 0 | 0 | ||
DERMIRA INC | COM | 24983L104 | 272 | 42,500 | SH | SOLE | 42,500 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 3,375 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 1,362 | 132,000 | SH | SOLE | 132,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 5,436 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
HOMOLOGY MEDICINES INC | COM | 438083107 | 4,073 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 13,674 | 1,705,000 | SH | SOLE | 1,705,000 | 0 | 0 | ||
INVESCO CURNCYSHS BRIT PND S | BRIT POUN STRL | 46138M109 | 12,593 | 105,600 | SH | SOLE | 105,600 | 0 | 0 | ||
INVESCO CURNCYSHS SWISS FRAN | SWISS FRANC | 46138R108 | 4,399 | 47,500 | SH | SOLE | 47,500 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 9,614 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 18,015 | 1,201,000 | SH | Call | SOLE | 1,201,000 | 0 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 9,100 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 3,654 | 315,000 | SH | SOLE | 315,000 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 4,410 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 4,383 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 4,536 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 21,425 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 2,886 | 242,950 | SH | SOLE | 242,950 | 0 | 0 | ||
PACIRA BIOSCIENCES | COM | 695127100 | 9,518 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 3,003 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
INVESCO QQQ TR | UNIT SER 1 | 46090E103 | 14,250 | 75,000 | SH | Put | SOLE | 75,000 | 0 | 0 | |
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 7,281 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 4,015 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 15,432 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 1,034 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | 30,000 | 100,000 | SH | Put | SOLE | 100,000 | 0 | 0 | |
SAREPTA THERAPEUTICS INC | COM | 803607100 | 16,570 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 13,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
TURNING POINT THERAPEUTICS I | COM | 90041T108 | 4,700 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
VIEWRAY INC | COM | 92672L107 | 2,393 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
SPDR SERIES TRUST | S&P BIOTECH | 78464A870 | 31,278 | 401,000 | SH | Put | SOLE | 401,000 | 0 | 0 |